Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.20
Bid: 77.00
Ask: 77.10
Change: 0.00 (0.00%)
Spread: 0.10 (0.13%)
Open: 76.60
High: 77.40
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

12 Jan 2015 17:03

RNS Number : 9575B
GCP Infrastructure Investments Ltd
12 January 2015
 



GCP Infrastructure Investments Limited

(the "Company")

 

Notice of Annual General Meeting

and resolution in connection with new placing programme

 

 

 

12 January 2015

 

The Directors of the Company are pleased to announce that the Notice of the 2015 Annual General Meeting ("Notice") to be held at 9 am on 12 February 2015 has today been posted or made available to Shareholders.

 

Amongst the resolutions to be proposed at the meeting will be a Special Resolution in connection with the proposed creation of a new placing programme (the "New Placing Programme") to replace the Company's existing Placing Programme when it reaches its planned closing date on 11 February 2015.

 

Special Resolution in connection with a New Placing Programme

The Company's Existing Placing Programme was instituted on 12 February 2014 and will close on 11 February 2015 (or any earlier date on which it is fully subscribed). The Company intends to institute a New Placing Programme pursuant to which it may issue up to 150,000,000 new Ordinary Shares.

The Company has issued 80,496,964 Ordinary Shares under the existing Placing Programme which has allowed it to take advantage of a number of attractive investment opportunities. Issuance of such Ordinary Shares has been at a premium to the Company's prevailing NAV per Ordinary Share, and therefore NAV accretive to Shareholders.

The Company continues to see significant opportunities in the infrastructure debt market and wishes to take advantage of these opportunities, against a background of continuing demand for the Company's Ordinary Shares (which have performed strongly and have traded at a premium to net asset value since the Company's IPO).

Any Ordinary Shares issued pursuant to the New Placing Programme will be issued at an issue price calculated by reference to the unaudited estimated prevailing net asset value per Ordinary Share (cum-income) at the time of allotment together with a premium intended to cover at least the costs and expenses of the relevant placing of Ordinary Shares (including, without limitation, any placing commissions) and the initial investment of the amounts raised. The minimum price in respect of an allotment of New Placing Programme Shares will not be less that the aggregate of the unaudited net asset value per Ordinary Share. The Board will consult with the Company's Investment Adviser and its brokers, and take into account the interests of Shareholders as a whole, market conditions, and the market rating of the Company's Ordinary Shares when determining the issue price for any such issuance.

The New Placing Programme will be flexible and may have a number of closing dates. The New Placing Programme will not be underwritten.

The Directors believe that instituting the New Placing Programme will have the following benefits for Shareholders:

· the Company will be able to raise additional capital quickly, which will enable it to take advantage of current and futureinvestment opportunities, thereby further diversifying its investment portfolio, both by number of investments and by sector;

 

· an increase in the market capitalisation of the Company will help to make the Company more attractive to a wider shareholder base;

 

· it is expected that the secondary market liquidity in the Ordinary Shares will be further enhanced as a result of a larger and more diversified shareholder base. The New Placing Programme will partially satisfy market demand for Ordinary Shares from time to time and improve liquidity in the market for Ordinary Shares; and

 

· the Company's fixed running costs will be spread across a wider shareholder base, thereby reducing the total expense ratio.

Shareholders are therefore being asked to approve by way of a Special Resolution at the AGM the disapplication of the pre-emption rights in the Articles in respect of the issue of up to 150,000,000 Ordinary Shares pursuant to the New Placing Programme.

The Company expects to publish a prospectus in respect of the New Placing Programme in due course.

The Notice has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.hemscott.com/nsm.do.

 

The Notice can also be obtained from the Company Secretary or from the Company's website, at:www.gcpuk.com/gcp-infrastructure-investments-ltd.

 Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

Oriel Securities Limited

+44 (0)20 7710 7600

Neil Winward

Mark Bloomfield

Cenkos Securitites

Dion Di Miceli

+44 (0)20 7397 1921

Tom Scrivens

+44 (0)20 7397 1915

Buchanan

Charles Ryland

+44 (0)20 7466 5000

Sophie McNulty

 

 

 

Note to Editors

 

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Partners LLP.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOABTMRTMBMBBBA
Date   Source Headline
29th Apr 20222:33 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSInvestor Report at 31 March 2022
27th Apr 202211:47 amRNSDirector/PDMR Shareholding
26th Apr 20222:32 pmRNSHolding(s) in Company
25th Apr 20227:00 amRNSDirector/PDMR Shareholding
21st Apr 202211:26 amRNSDividend Declaration & Scrip Dividend Alternative
14th Apr 20224:12 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSNet Asset Value(s)
31st Mar 20227:00 amRNSTotal Voting Rights
8th Mar 20229:46 amRNSAdditional Listing and Total Voting Rights
24th Feb 20229:25 amRNSAdditional Listing
21st Feb 20227:00 amRNSDirector Declaration
14th Feb 20223:03 pmRNSResult of AGM
26th Jan 20221:26 pmRNSDirector/PDMR Shareholding
26th Jan 20221:24 pmRNSDirector/PDMR Shareholding
21st Jan 202212:10 pmRNSDividend Declaration & Scrip Dividend Alternative
21st Jan 20227:00 amRNSInvestor Report at 31 December 2021
18th Jan 20223:31 pmRNSUpdate research from QuotedData
17th Jan 20227:00 amRNSNet Asset Value(s)
10th Jan 20228:00 amRNSNotice of AGM
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSDirector Declaration
14th Dec 20217:00 amRNSAnnual report and financial statements
9th Dec 202110:39 amRNSDirector/PDMR Shareholding
9th Dec 20218:41 amRNSAdditional Listing and Total Voting Rights
1st Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:09 amRNSAdditional Listing
11th Nov 20217:00 amRNSScrip Share Reference Price
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
28th Oct 20211:54 pmRNSDividend Declaration & Scrip Dividend Alternative
19th Oct 20217:00 amRNSNet Asset Value(s)
30th Sep 20217:00 amRNSTotal Voting Rights
17th Sep 20215:23 pmRNSNew Directorship Notification
9th Sep 202111:47 amRNSDirector/PDMR Shareholding
9th Sep 202111:47 amRNSAdditional Listing and Total Voting Rights
3rd Sep 20214:15 pmRNSNew Directorship Notification
27th Aug 202110:19 amRNSAdditional Listing
12th Aug 20217:00 amRNSScrip share reference price
9th Aug 202111:42 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021 and RCF update
28th Jul 20217:00 amRNSDividend Declaration & Scrip Dividend Alternative
20th Jul 202110:59 amRNSUpdate research from QuotedData
16th Jul 20219:21 amRNSDirector/PDMR Shareholding
15th Jul 20217:00 amRNSNet Asset Value(s)
1st Jul 202110:55 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSTotal Voting Rights
22nd Jun 202110:20 amRNSDirector/PDMR Shareholding
21st Jun 20211:21 pmRNSDirector/PDMR Shareholding
10th Jun 20217:00 amRNSHalf-yearly report and financial statements 2021
8th Jun 202112:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.